Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Aquagen International is a health and wellness company specializing in the development and distribution of stabilized oxygen supplements. The company utilizes a proprietary manufacturing process to create a liquid supplement designed to increase oxygen levels in the body, targeting athletes and individuals seeking improved energy and recovery. Their flagship product, Aquagen, is marketed as a safe, non-toxic solution for oxygen supplementation. The company's technology focuses on bonding oxygen molecules to water, allowing for oral consumption and absorption. Aquagen International operates primarily in the consumer health sector and distributes its products globally.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Aquagen International.